oral+semaglutide+vs+trulicity Comparing Ozempic, Wegovy and Other GLP-1 Drugs What is the recommended dosing

Effective treatment of obesity could have far-reaching consequences that extend beyond just weight management, affecting metabolic parameters such as heart disease and even cancer

The newly approved Wegovy HD (semaglutide) injection 7.2 mg is for patients who have already tolerated the currently approved 2.4 mg dose and require additional weight reduction

With conditions such as hypothyroidism, reducing inflammation and implementing a whole-foods based diet can help patients achieve weight loss

Increased risk of low blood sugar (hypoglycemia) in patients with type 2 diabetes, especially those who also take medications for type 2 diabetes such as sulfonylureas or insulin